Replies to post #31012 on PharmaCyte Biotech Inc (PMCB)

[Peacefulwendy]

"The first preclinical study by TD2 in the U.S. that deals with the effectiveness of PharmaCyte Biotech's pancreatic cancer treatment on the accumulation of malignant ascites fluid that is often associated with the growth of abdominal cancers, including pancreatic cancer, has been completed and positive results were obtained."

http://globenewswire.com/news-release/2014/12/16/691741/10112491/en/Nuvilex-Provides-Shareholder-Update-on-Cancer-and-Diabetes-Programs.html